Top Stories: Dicerna Pharmaceuticals (NASDAQ:DRNA), Merck & Co. Inc. (NYSE:MRK), Apple Inc. (NASDAQ:AAPL), News Corporation (NASDAQ:NWSA), Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)
On Monday shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) closed at $20.27. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) announced the commencement of a proposed underwritten public offering of 2,750,000 shares of common stock. Dicerna also intends to grant the underwriters a 30-day optionRead More